Eagle Asset Management’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-315,520
| Closed | -$6.77M | – | 576 |
|
|
2023
Q4 | $6.77M | Buy |
315,520
+26,387
| +9% | +$566K | 0.04% | 335 |
|
|
2023
Q3 | $5.96M | Sell |
289,133
-5,658
| -2% | -$117K | 0.04% | 330 |
|
|
2023
Q2 | $8.7M | Sell |
294,791
-8,170
| -3% | -$241K | 0.05% | 281 |
|
|
2023
Q1 | $6.98M | Sell |
302,961
-26,123
| -8% | -$602K | 0.04% | 298 |
|
|
2022
Q4 | $9.09M | Buy |
329,084
+73,624
| +29% | +$2.03M | 0.06% | 249 |
|
|
2022
Q3 | $7.84M | Sell |
255,460
-8,244
| -3% | -$253K | 0.05% | 270 |
|
|
2022
Q2 | $7.76M | Buy |
263,704
+59,854
| +29% | +$1.76M | 0.05% | 283 |
|
|
2022
Q1 | $6.56M | Buy |
203,850
+12,334
| +6% | +$397K | 0.03% | 345 |
|
|
2021
Q4 | $8.63M | Sell |
191,516
-51,029
| -21% | -$2.3M | 0.04% | 332 |
|
|
2021
Q3 | $12.2M | Sell |
242,545
-48,558
| -17% | -$2.45M | 0.06% | 278 |
|
|
2021
Q2 | $22.8M | Sell |
291,103
-26,759
| -8% | -$2.1M | 0.1% | 226 |
|
|
2021
Q1 | $17.8M | Buy |
317,862
+18,676
| +6% | +$1.04M | 0.08% | 247 |
|
|
2020
Q4 | $25.1M | Buy |
+299,186
| New | +$25.1M | 0.14% | 205 |
|